Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celsion's Newest Cancer Treatment Adds To Upside
Seeking Alpha
Friday, February 14, 2014 - 11:49am
tags:
Celsion, ThermoDox, glioblastoma multiforme
AbbVie Deserves More Respect
TheStreet.com
Friday, February 14, 2014 - 10:50am
tags:
AbbVie
Pfizer Needs a Healthy Dose of Investor Love
Yahoo/TheStreet.com
Friday, February 14, 2014 - 10:49am
tags:
Pfizer, Zoetis
IPO Preview: Semler Scientific
Seeking Alpha
Friday, February 14, 2014 - 10:40am
tags:
Semler Scientific, IPOs, devices
A Deeper Look At The Galena Biopharma Controversy
Seeking Alpha
Friday, February 14, 2014 - 10:38am
tags:
Galena Biopharma
3 Promising Biotechs for 2014: Ariad, Bristol-Myers, Sanomedics
Wall St Cheat Sheet
Friday, February 14, 2014 - 10:36am
tags:
Ariad Pharmaceuticals, Bristol-Myers Squibb, Sanomedics
Bayer says FDA rejects wider use of Xarelto drug
Yahoo/Reuters
Friday, February 14, 2014 - 9:49am
tags:
FDA, Bayer, Xarelto
Bayer says FDA rejects wider use of Xarelto drug
Yahoo/Reuters
Friday, February 14, 2014 - 9:49am
tags:
FDA, Bayer, Xarelto
Medicines Co. shares plummet after FDA follows through with rejection
Marketwatch
Thursday, February 13, 2014 - 11:51am
tags:
FDA, Cangrelor, The Medicines Company
Hackers break into networks of 3 big medical device makers
SF Gate, CA
Thursday, February 13, 2014 - 11:21am
tags:
devices, Medtronic, hacking, Boston Scientific, St. Jude Medical
[video]Everyone Wins in This Big Pharma Buyout
Motley Fool
Thursday, February 13, 2014 - 11:18am
tags:
Mallinckrodt, M&A, Cadence Pharmaceuticals
Third Rock puts up $45M for a voyage into gene therapy
Fierce Biotech
Thursday, February 13, 2014 - 11:14am
tags:
Third Rock, gene therapy, Voyager Therapeutics
Novartis aims for super-speed with strategic review, CEO tells analysts
Fierce Pharma
Thursday, February 13, 2014 - 11:10am
tags:
Novartis, Joe Jimenez, Pharma CEOs
Marginal Earnings Beat at Hospira in Q4
Yahoo/Zacks.com
Thursday, February 13, 2014 - 10:58am
tags:
Hospira, earnings
Incyte Shows Its Path Towards Growth
Seeking Alpha
Thursday, February 13, 2014 - 9:31am
tags:
Incyte, Jakafi
Antibiotic Companies To Cash In On In 2014
Seeking Alpha
Thursday, February 13, 2014 - 9:25am
tags:
antibiotics, Optimer Pharmaceuticals, Trius Therapeutics, Solithromycin, Cempra
FDA rejects Durect's pitch to market post-operative pain therapy
Fierce Biotech
Thursday, February 13, 2014 - 9:22am
tags:
FDA, Durect, post-operative pain
Shire's strong earnings outlook sends shares to new high
Reuters
Thursday, February 13, 2014 - 9:19am
tags:
earnings, Shire
The Zacks Analyst Blog Highlights: Gilead, Cytokinetics, Puma, Biogen and Spectrum Pharmaceuticals
Yahoo/Zacks.com
Thursday, February 13, 2014 - 9:18am
tags:
Gilead Sciences, Cytokinetics, Puma Biotechnology, Biogen Idec, Spectrum Pharmaceuticals
Pfizer Sued by Australian Regulator Over Generic Lipitor
Bloomberg
Thursday, February 13, 2014 - 9:15am
tags:
Pfizer, generics, Lipitor, Australia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.